Key facts
- BioScout’s last known valuation is $4.0M (Jun 2022).
- It has raised $3.2M; the latest was Later Stage VC in Sep 2025.
- Notable investors include SparkLabs Group, Artesian, Blackbird Ventures, Startmate, Global Agri-Food Advancement Partnership — 12 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 12 names
- ·Watchlist + deal alerts for BioScout
- ·The full record, as it builds
Funding rounds
No funding rounds for BioScout are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About BioScout
Developer of an integrated hardware and software platform designed to track the spread of airborne diseases. The company's platform offers automated air sampling with integrated environmental sensors, artificial intelligence analysis, and real-time reporting, enabling farmers and agronomists to monitor fungal threats across their fields, make informed crop protection decisions, and support healthier, more productive agricultural outcomes.
- Sector
- Information Technology
- HQ
- Marrickville, Australia
- Founded
- 2017
- Employees
- 34
- Website
- bioscout.com.au/
- Ownership
- Privately Held (backing)
BioScout doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in BioScout shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on BioScout in its N-PORT filings yet. We sweep new filings monthly.